- Home
- ANTX vs BOWN Comparison
ANTX vs BOWN Comparison
Compare ANTX & BOWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTX
- BOWN
- Stock Information
- Founded
- ANTX 2017
- BOWN 2023
- Country
- ANTX United States
- BOWN United States
- Employees
- ANTX N/A
- BOWN N/A
- Industry
- ANTX Biotechnology: Pharmaceutical Preparations
- BOWN
- Sector
- ANTX Health Care
- BOWN
- Exchange
- ANTX Nasdaq
- BOWN Nasdaq
- Market Cap
- ANTX 33.2M
- BOWN 28.5M
- IPO Year
- ANTX 2022
- BOWN 2023
- Fundamental
- Price
- ANTX $1.07
- BOWN $9.14
- Analyst Decision
- ANTX Buy
- BOWN
- Analyst Count
- ANTX 2
- BOWN 0
- Target Price
- ANTX $2.00
- BOWN N/A
- AVG Volume (30 Days)
- ANTX 254.6K
- BOWN 2.5K
- Earning Date
- ANTX 08-12-2025
- BOWN 01-01-0001
- Dividend Yield
- ANTX N/A
- BOWN N/A
- EPS Growth
- ANTX N/A
- BOWN N/A
- EPS
- ANTX N/A
- BOWN 0.02
- Revenue
- ANTX N/A
- BOWN N/A
- Revenue This Year
- ANTX N/A
- BOWN N/A
- Revenue Next Year
- ANTX N/A
- BOWN N/A
- P/E Ratio
- ANTX N/A
- BOWN $206.51
- Revenue Growth
- ANTX N/A
- BOWN N/A
- 52 Week Low
- ANTX $0.87
- BOWN $2.71
- 52 Week High
- ANTX $3.07
- BOWN $19.77
- Technical
- Relative Strength Index (RSI)
- ANTX 45.67
- BOWN 42.74
- Support Level
- ANTX $1.05
- BOWN $8.70
- Resistance Level
- ANTX $1.11
- BOWN $10.20
- Average True Range (ATR)
- ANTX 0.04
- BOWN 0.39
- MACD
- ANTX 0.00
- BOWN 0.00
- Stochastic Oscillator
- ANTX 33.33
- BOWN 36.57
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.
About BOWN Bowen Acquisition Corp
Bowen Acquisition Corp is a blank check company.